Work productivity in a population-based cohort of patients with spondyloarthritis.
(2013) In Rheumatology 52(9). p.1708-1714- Abstract
- Objective. To assess work productivity and associated factors in patients with SpA.Methods. This cross-sectional postal survey included 1773 patients with SpA identified in a regional health care register. Items on presenteeism (reduced productivity at work, 0-100%, 0 = no reduction) were answered by 1447 individuals. Absenteeism was defined as register-based sick leave using data from a national register. Disease duration, disease activity (BASDAI), physical function (BASFI), health-related quality of life (EQ-5D), anxiety (HAD-a), depression (HAD-d), self-efficacy [Arthritis Self-efficacy Scale (ASES) pain and symptom], physical activity and education were also measured.Results. Forty-five per cent reported reduced productivity at work... (More)
- Objective. To assess work productivity and associated factors in patients with SpA.Methods. This cross-sectional postal survey included 1773 patients with SpA identified in a regional health care register. Items on presenteeism (reduced productivity at work, 0-100%, 0 = no reduction) were answered by 1447 individuals. Absenteeism was defined as register-based sick leave using data from a national register. Disease duration, disease activity (BASDAI), physical function (BASFI), health-related quality of life (EQ-5D), anxiety (HAD-a), depression (HAD-d), self-efficacy [Arthritis Self-efficacy Scale (ASES) pain and symptom], physical activity and education were also measured.Results. Forty-five per cent reported reduced productivity at work with a mean reduction of 20% (95% CI 18, 21) and women reported a higher mean reduction than men (mean 23% vs 17%, P < 0.001). Worse quality of life, disease activity, physical function and anxiety all correlated with reduced productivity (r = 0.52-0.66, P < 0.001), while sick leave did not. Worse outcomes on the EQ-5D (β-est -9.6, P < 0.001), BASDAI (β-est 7.8, P < 0.001), BASFI (β-est 7.3, P < 0.001), ASES pain (β-est -0.5, P < 0.001) and HAD-d (β-est 3.4, P < 0.001) were associated with reduced productivity at work in patients with SpA regardless of age, gender and disease subgroup. ASES symptoms, HAD-a and education level <12 years were associated with reduced productivity but were not significant in all strata for age, gender and disease subgroup.Conclusion. Work productivity was reduced in patients with SpA and more so in women. Worse quality of life, disease activity, physical function, self-efficacy and depression were all associated with reduced productivity at work in patients with SpA. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3912949
- author
- Haglund, Emma LU ; Bremander, Ann LU ; Bergman, Stefan LU ; Jacobsson, Lennart LU and Petersson, Ingemar LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Rheumatology
- volume
- 52
- issue
- 9
- pages
- 1708 - 1714
- publisher
- Oxford University Press
- external identifiers
-
- wos:000323348000027
- pmid:23804223
- scopus:84883010473
- pmid:23804223
- ISSN
- 1462-0332
- DOI
- 10.1093/rheumatology/ket217
- language
- English
- LU publication?
- yes
- id
- 0b1bb44b-c1bc-4f8b-9307-c5f3acafdf28 (old id 3912949)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23804223?dopt=Abstract
- date added to LUP
- 2016-04-01 10:38:22
- date last changed
- 2022-04-27 23:59:58
@article{0b1bb44b-c1bc-4f8b-9307-c5f3acafdf28,
abstract = {{Objective. To assess work productivity and associated factors in patients with SpA.Methods. This cross-sectional postal survey included 1773 patients with SpA identified in a regional health care register. Items on presenteeism (reduced productivity at work, 0-100%, 0 = no reduction) were answered by 1447 individuals. Absenteeism was defined as register-based sick leave using data from a national register. Disease duration, disease activity (BASDAI), physical function (BASFI), health-related quality of life (EQ-5D), anxiety (HAD-a), depression (HAD-d), self-efficacy [Arthritis Self-efficacy Scale (ASES) pain and symptom], physical activity and education were also measured.Results. Forty-five per cent reported reduced productivity at work with a mean reduction of 20% (95% CI 18, 21) and women reported a higher mean reduction than men (mean 23% vs 17%, P < 0.001). Worse quality of life, disease activity, physical function and anxiety all correlated with reduced productivity (r = 0.52-0.66, P < 0.001), while sick leave did not. Worse outcomes on the EQ-5D (β-est -9.6, P < 0.001), BASDAI (β-est 7.8, P < 0.001), BASFI (β-est 7.3, P < 0.001), ASES pain (β-est -0.5, P < 0.001) and HAD-d (β-est 3.4, P < 0.001) were associated with reduced productivity at work in patients with SpA regardless of age, gender and disease subgroup. ASES symptoms, HAD-a and education level <12 years were associated with reduced productivity but were not significant in all strata for age, gender and disease subgroup.Conclusion. Work productivity was reduced in patients with SpA and more so in women. Worse quality of life, disease activity, physical function, self-efficacy and depression were all associated with reduced productivity at work in patients with SpA.}},
author = {{Haglund, Emma and Bremander, Ann and Bergman, Stefan and Jacobsson, Lennart and Petersson, Ingemar}},
issn = {{1462-0332}},
language = {{eng}},
number = {{9}},
pages = {{1708--1714}},
publisher = {{Oxford University Press}},
series = {{Rheumatology}},
title = {{Work productivity in a population-based cohort of patients with spondyloarthritis.}},
url = {{https://lup.lub.lu.se/search/files/2015886/4144973.pdf}},
doi = {{10.1093/rheumatology/ket217}},
volume = {{52}},
year = {{2013}},
}